You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Zytiga

Showing 101 - 123 of 123
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Philadelphia (Alisertib,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Nov 8, 2017

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue

Recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Abiraterone Acetate
  • +6 more
  • Fairbanks, Alaska
  • +671 more
Dec 29, 2021

Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Los Angeles (abiraterone

Unknown status
  • Hormone-resistant Prostate Cancer
  • +2 more
  • abiraterone acetate
  • +2 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Jul 5, 2017

Metastatic Castration-Resistant Prostatic Cancer Trial in Australia, Canada (cabazitaxel, Abiraterone, Enzalutamide 160mg daily

Unknown status
  • Metastatic Castration-Resistant Prostatic Cancer
  • Box Hill, Victoria, Australia
  • +14 more
Dec 4, 2017

Prostate Cancer Trial in New York (Abiraterone Acetate)

Terminated
Has Results
  • Prostate Cancer
  • Abiraterone Acetate
  • New York, New York
  • +1 more
Apr 4, 2017

Adenocarcinoma of the Prostate, Stage II Prostate Cancer, Stage III Prostate Cancer Trial in Seattle, Tacoma (drug, other,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • abiraterone acetate
  • +5 more
  • Seattle, Washington
  • +1 more
May 3, 2017

Cushing Syndrome, Adrenocortical Carcinoma Trial in Brescia (Abiraterone Acetate)

Unknown status
  • Cushing Syndrome
  • Adrenocortical Carcinoma
  • Abiraterone Acetate
  • Brescia, BS, Italy
    U.O Oncologia Medica
May 9, 2017

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Portland (drug, dietary

Terminated
  • Adenocarcinoma of the Prostate
  • +3 more
  • abiraterone acetate
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Apr 26, 2017

Prostate Cancer Trial in Chur, Basel, St.Gallen (abiraterone acetate)

Terminated
  • Prostate Cancer
  • abiraterone acetate
  • Chur, Graubuenden, Switzerland
  • +2 more
Mar 22, 2017

Prostate Cancer Trial in Switzerland (Orteronel, Placebo)

Withdrawn
  • Prostate Cancer
  • Baden, Switzerland
  • +6 more
Jul 26, 2018

Cancer Trial (Afuresertib, Enzalutamide, Abiraterone)

Withdrawn
  • Cancer
  • (no location specified)
Oct 5, 2016

Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone 5 mg twice daily, Prednisone 5 mg once daily)

Completed
Has Results
  • Prostate Cancer
  • Abiraterone Acetate
  • +4 more
  • Aalst, Belgium
  • +16 more
Jul 2, 2019

Urokinase Plasminogen Activator Receptor in Abiraterone Treated

Terminated
  • Prostatic Neoplasms
  • Copenhagen, Denmark
    University Hospital of Copenhagen, Rigshospitalet
Nov 18, 2015

CTCs and ctDNA in Blood and Plasma Samples From Metastatic

Terminated
  • Hormone-Resistant Prostate Cancer
  • Metastatic Prostate Carcinoma
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Apr 13, 2017

Prostate Cancer, Metastatic Prostate Cancer, Androgen-independent Prostate Cancer Trial in Sutton Surrey (onapristone,

Unknown status
  • Prostate Cancer
  • +3 more
  • Sutton Surrey, United Kingdom
    Inst of Cancer Research & Royal Marsden NHS Foundation Trust
Jun 22, 2015

Prostate Cancer, Localized Prostate Cancer Trial in Baltimore (Enzalutamide, Abiraterone acetate, Prednisone)

Withdrawn
  • Prostate Cancer
  • Localized Prostate Cancer
  • Baltimore, Maryland
    Johns Hopkins Hospital
Jan 22, 2015

Prostate Cancer, Castration Resistant Prostate Cancer, Prostatic Tumors Trial in United States (cabozantinib, abiraterone,

Terminated
  • Prostate Cancer
  • +2 more
  • Scottsdale, Arizona
  • +19 more
Feb 19, 2015

Resistance in Castrate Resistant Prostate Cancer Treated With

Completed
  • Prostate Cancer (Adenocarcinoma)
    • Vancouver, British Columbia, Canada
    • +1 more
    Jun 19, 2015

    Healthy Trial in Beijing (Treatment A: abiraterone acetate, Treatment B: abiraterone acetate, Treatment C: abiraterone acetate)

    Completed
    • Healthy
    • Treatment A: abiraterone acetate
    • +2 more
    • Beijing, China
      (unnamed)
    Sep 5, 2013

    Healthy Volunteers Trial in Tempe (Treatment A, Treatment B, Treatment C)

    Completed
    • Healthy Volunteers
    • Treatment A
    • +4 more
    • Tempe, Arizona
      (unnamed)
    Nov 27, 2014

    Healthy Participants Trial in Tempe (Abiraterone acetate, 250 mg (uncoated, current commercial tablet), Abiraterone acetate, 500

    Completed
    • Healthy Participants
    • Abiraterone acetate, 250 mg (uncoated, current commercial tablet)
    • +3 more
    • Tempe, Arizona
      (unnamed)
    Mar 1, 2013

    Healthy Trial in Merksem (Abiraterone acetate, Rifampicin)

    Completed
    • Healthy
    • Merksem, Belgium
      (unnamed)
    Jan 8, 2013

    Healthy Volunteers Trial (Abiraterone acetate suspension Formulation 1, Abiraterone acetate suspension Formulation 2,

    Completed
    • Healthy Volunteers
    • Abiraterone acetate suspension Formulation 1
    • +2 more
    • (no location specified)
    Nov 26, 2012